TScan Therapeutics

We are excited (but not surprised) to announce TScan has been named a Top Place to Work by The Boston Globe for two consecutive years! Interested in joining our mission-focused team with an industry-leading culture? Check out our job openings: https://bit.ly/3GoUGAW #WorkBoston #CellTherapy

"Early awareness can save lives." In honor of National Cancer Survivor Month, we are sharing stories from #TScanners about how cancer has impacted their lives. These stories of survivorship come from Christina, our Senior Lab Manager, who shares her family's journey.   Christina wears three pins representing her loved ones who have fought cancer and won!   One pin is for her sister, recently diagnosed with thyroid cancer during a routine check-up. Despite the nerve-wracking weeks of waiting for her sister's biopsy results, the cancer was caught early. Her sister's care team operated quickly, and the surgery was successful. Christina shares, "We're so thankful her doctor was able to detect such a small tumor to begin with."   Her second pin honors her sister’s father-in-law, who has bravely battled blood cancer for several years. He has been cancer-free for over one year following successful treatment with CAR-T therapy!   Her third pin is for her aunt, a breast cancer survivor. This pin is especially significant as her grandmother died of ovarian cancer. Her aunt's diagnosis led her aunt, mother, and all their sisters to undergo BRCA1 genetic testing, promoting early awareness and proactive measures.   Christina emphasizes, "Early awareness can save lives. Unfortunately, the balance in my family still skews in the wrong direction, but with advancements in genetic testing, early diagnoses, and therapies, we can hopefully see that balance shift in the future!"   We thank Christina for sharing her family's inspiring stories of triumph over cancer. Let's continue the fight! #NationalCancerSurvivorMonth

“Ask for the test. Ask for the procedure. Be your own advocate."   In honor of National Cancer Survivor Month, we are sharing stories from #TScanners about how cancer has impacted their lives. This story comes from Pam, a valued member of our supply chain team and a cancer survivor herself, who reflects on her brother’s experience with cancer.   Pam's brother, Mark, was a healthy 44-year-old with a loving family, many friends, and a great laugh that could light up any room. In 2005, he began experiencing severe stomach issues and fatigue, even needing to pull over for naps while driving. Despite being treated for acid reflux for nearly a year, his condition didn't improve. Finally, he admitted that 'something is wrong'. He sought out scans and tests and was diagnosed with stage 4 stomach cancer. Mark bravely fought for six more months before losing his battle to cancer. Pam is deeply grateful to Dana Farber and Brigham and Women's Hospital for their exceptional care of Mark during his time there.   We honor Mark's story as a reminder of the importance of self-advocacy in healthcare. Pam shares, "Ask for the test. Ask for the procedure. Be your own advocate. My brother's story is one of the reasons I came to TScan Therapeutics. Let's help find a cure and beat cancer.”   We thank Pam for her courage in sharing his story, which reminds us to continue the fight against cancer. #NationalCancerSurvivorMonth

Today we welcome Garry Nicholson to TScan’s board of directors. Garry brings extensive experience across oncology development and commercialization to TScan, and his support will be invaluable as we advance our novel pipeline of #TCRT therapies. https://bit.ly/3KKybIS

This #NationalCancerSurvivorMonth, we stand with cancer survivors to celebrate their strength and resilience. Their stories inspire us to strive for a future where all cancer is cured. Together, we honor their journey, support their continued health, and remain committed to advancing research and treatment. Let's amplify awareness, inspire hope, and work towards a world without cancer! #TScan #UnleashImmunity

Today we announced that the Company will present at the Jefferies Global Healthcare Conference being held at the Marriott Marquis in NYC on 6/5 at 11:00 am ET. Read the press release for webcast details: https://bit.ly/3R8a8Hv #CellTherapy #TCells

We are pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to TSC-100 and TSC-101, the Company’s two lead TCR-T therapy candidates for the treatment of heme #Malignancies: [https://bit.ly/3VhT0S6] #CellTherapy

We are gearing up for #ASCO24 where we will present two posters: (1) heme malignancies Ph1 trial design (poster 152B) and (2) a screening update from the Ph1 #SolidTumor program (poster 21). Drop by Hall A on 6/1 from 9-12pm CT to learn more! #CellTherapy  

Calling all #CellTherapy #Manufacturing professionals: we're hiring at #TScan! https://lnkd.in/escmM9NJ #BiotechJobs #UnleashImmunity

Today we reported first quarter financial results and provided a corporate update. Read the press release to learn more about our recent accomplishments and upcoming anticipated milestones: https://bit.ly/3UW2nGG #CellTherapy #UnleashImmunity #TCells